Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18748984 | DEVICES, SYSTEMS AND METHODS FOR EVALUATION AND FEEDBACK OF NEUROMODULATION TREATMENT | June 2024 | June 2025 | Allow | 12 | 0 | 0 | No | No |
| 18746503 | METHOD AND SYSTEM FOR ELECTRICAL NERVE STIMULATION | June 2024 | October 2025 | Allow | 16 | 1 | 2 | No | No |
| 18669525 | CARDIAC PACING LEAD | May 2024 | July 2025 | Allow | 14 | 2 | 1 | No | No |
| 18629088 | DEVICES AND METHODS FOR TREATING MOTION SICKNESS USING ELECTRICAL STIMULATION | April 2024 | September 2024 | Allow | 6 | 1 | 0 | No | No |
| 18612879 | TECHNIQUES FOR MIGRAINE DETECTION USING A WEARABLE DEVICE | March 2024 | February 2026 | Allow | 23 | 0 | 0 | No | No |
| 18608203 | TRANSCUTANEOUS ELECTRICAL STIMULATION TREATMENT OF HEADACHE | March 2024 | November 2024 | Allow | 8 | 1 | 1 | Yes | No |
| 18440703 | VENTRICULAR FAR-FIELD SENSING TO GUIDE ATRIAL LEADLESS PACEMAKER AND BEYOND | February 2024 | January 2025 | Allow | 11 | 1 | 1 | No | No |
| 18404769 | ELECTROCARDIOGRAPHIC IDENTIFICATION OF NON-ST ELEVATION ISCHEMIC EVENTS | January 2024 | June 2025 | Allow | 17 | 2 | 1 | Yes | No |
| 18397061 | WEARABLE CARDIOVERTER DEFIBRILLATOR HAVING REDUCED NOISE PROMPTS | December 2023 | February 2025 | Allow | 14 | 1 | 1 | No | No |
| 18541938 | NEUROSTIMULATION TITRATION PROCESS VIA ADAPTIVE PARAMETRIC MODIFICATION | December 2023 | December 2024 | Allow | 12 | 0 | 0 | No | No |
| 18535669 | SYNERGISTIC MUSCLE ACTIVATION DEVICE | December 2023 | March 2025 | Allow | 15 | 0 | 0 | No | No |
| 18532472 | Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields) | December 2023 | August 2024 | Allow | 8 | 1 | 0 | No | No |
| 18532490 | Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields) | December 2023 | August 2024 | Allow | 8 | 1 | 0 | No | No |
| 18530638 | STIMULATION DESIGN FOR NEUROMODULATION | December 2023 | December 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18522806 | METHOD AND SYSTEM FOR ACQUIRING DATA FOR ASSESSMENT OF CARDIOVASCULAR DISEASE | November 2023 | July 2024 | Allow | 8 | 1 | 0 | No | No |
| 18563692 | MEMORY ENHANCEMENT BY PREFRONTAL DEEP BRAIN STIMULATION SYNCHRONIZED TO MEDIAL TEMPORAL LOBE DURING SLEEP | November 2023 | February 2026 | Allow | 27 | 1 | 0 | Yes | No |
| 18514364 | METHOD AND SYSTEM FOR CARDIOVASCULAR DISEASE ASSESSMENT AND MANAGEMENT | November 2023 | June 2024 | Allow | 7 | 0 | 0 | No | No |
| 18558767 | Implantable Medical Device Comprising an Electrical Line Forming an Antenna | November 2023 | February 2026 | Allow | 27 | 1 | 0 | No | No |
| 18386491 | NEUROSTIMULATION AND MONITORING USING SENSOR ENABLED WOUND MONITORING AND THERAPY APPARATUS | November 2023 | March 2025 | Allow | 16 | 1 | 1 | No | No |
| 18556872 | SELF-SUFFICIENT NEURAL TISSUE STIMULATOR | October 2023 | January 2026 | Allow | 27 | 1 | 0 | No | No |
| 18474992 | TRANSCUTANEOUS ELECTRICAL STIMULATION TREATMENT OF MIGRAINES AND HEADACHES | September 2023 | February 2024 | Allow | 5 | 0 | 0 | No | No |
| 18474952 | ROBUST ADAPTIVE BRAIN STIMULATION | September 2023 | September 2024 | Allow | 12 | 1 | 0 | No | No |
| 18464914 | Pulse Definition Circuitry for Creating Stimulation Waveforms in an Implantable Pulse Generator | September 2023 | March 2025 | Allow | 19 | 1 | 0 | No | No |
| 18242939 | SYSTEMS AND METHODS FOR TREATMENT OF DRY EYE | September 2023 | February 2025 | Abandon | 17 | 1 | 0 | Yes | No |
| 18241552 | Intravaginal Electrical Stimulation Device for Treating Female Pelvic Pain | September 2023 | February 2026 | Allow | 29 | 0 | 1 | No | No |
| 18238786 | FLUID PUMP CHANGEABLE IN DIAMETER, IN PARTICULAR FOR MEDICAL APPLICATION | August 2023 | August 2025 | Allow | 24 | 0 | 0 | No | No |
| 18456202 | SYSTEMS AND METHODS FOR IMPROVED SPINAL CORD STIMULATION | August 2023 | April 2024 | Allow | 7 | 1 | 0 | No | No |
| 18451801 | MATERIAL AND APPAREL THAT POSITIVELY AFFECT THE HEALTH AND WELLBEING OF A MAMMAL | August 2023 | November 2024 | Allow | 15 | 4 | 0 | No | No |
| 18546765 | PERIPHERAL NERVE AND SPINAL CORD DIFFERENTIAL TARGET MULTIPLEXED STIMULATION | August 2023 | January 2026 | Allow | 29 | 1 | 0 | No | No |
| 18449855 | WEARABLE CARDIOVERTER DEFIBRILLATOR HAVING ADJUSTABLE ALARM TIME | August 2023 | July 2024 | Allow | 11 | 1 | 0 | No | No |
| 18263725 | 5G Implant | August 2023 | March 2026 | Allow | 31 | 2 | 0 | No | No |
| 18261872 | Implantable Pulse Generator Having a Pulse Generation Device | July 2023 | January 2026 | Allow | 30 | 1 | 1 | No | No |
| 18220059 | HEART FAILURE MANAGEMENT TO AVOID REHOSPITALIZATION | July 2023 | September 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18330311 | Implantable Electrode Positioning | June 2023 | June 2024 | Allow | 12 | 0 | 0 | No | No |
| 18205274 | BIOELECTRIC NEUROMODULATION FOR HEMATOPOIESIS REGULATION DURING CHEMOTHERAPY | June 2023 | October 2025 | Allow | 28 | 1 | 0 | No | No |
| 18202834 | DEVICES AND METHODS FOR TREATING MOTION SICKNESS USING ELECTRICAL STIMULATION | May 2023 | February 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18201140 | CARDIAC PACING LEAD | May 2023 | March 2024 | Allow | 10 | 1 | 1 | No | No |
| 18322190 | MEDICAL IMPLANTS WITH CIRCUITS TREATING PERIPROSTHETIC JOINT INFECTION AND OTHER SENSING | May 2023 | January 2026 | Allow | 32 | 1 | 1 | No | No |
| 18322125 | MEDICAL IMPLANTS WITH CIRCUITS TREATING PERIPROSTHETIC JOINT INFECTION AND OTHER SENSING | May 2023 | January 2026 | Allow | 31 | 1 | 0 | No | No |
| 18036882 | SYSTEMS AND METHODS FOR ANALYSIS OF PULSE AND PHYSIOLOGICAL, PATHOLOGICAL, AND EMOTIONAL STATE AND APPLICATIONS THEREOF | May 2023 | September 2025 | Allow | 28 | 0 | 1 | Yes | No |
| 18249524 | NOCICEPTION EVENT IDENTIFICATION BASED ON A RELATIVE CHANGE IN A NOCICEPTION PARAMETER | April 2023 | February 2026 | Allow | 34 | 2 | 0 | Yes | No |
| 18301922 | Methods and Devices for Treating Sleep Apnea | April 2023 | July 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18134154 | Prevention of Aortic Valve Fusion | April 2023 | May 2024 | Allow | 13 | 0 | 1 | No | No |
| 18133091 | Contingent Cardio-Protection for Epilepsy Patients | April 2023 | June 2024 | Allow | 14 | 1 | 1 | No | No |
| 18193004 | INCONTINENCE THERAPY | March 2023 | December 2023 | Allow | 9 | 0 | 0 | No | No |
| 18151778 | ADJUSTABLE AURICULAR NERVE STIMULATION DEVICES, AND ASSOCIATED SYSTEMS AND METHODS | January 2023 | October 2025 | Allow | 33 | 1 | 0 | No | No |
| 18063457 | WEARABLE MEDICAL SYSTEM WITH DEVICE PARAMETERS AND PATIENT INFORMATION PROGRAMMABLE VIA BROWSER INTERFACE | December 2022 | January 2026 | Allow | 38 | 2 | 0 | No | No |
| 17928079 | ELECTRODE PLATE AND WEARABLE DEFIBRILLATION DEVICE | November 2022 | September 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17927806 | AN ELECTROPHYSIOLOGY SYSTEM | November 2022 | June 2025 | Allow | 30 | 0 | 0 | No | No |
| 17999428 | DEVICE FOR APPLYING MEDICAL AND COSMETIC RADIATION TO A HUMAN BODY OR TO PARTS OF A HUMAN BODY | November 2022 | February 2026 | Allow | 39 | 1 | 1 | No | No |
| 17991136 | DEVICE, A SYSTEM, AND A METHOD FOR MONITORING BONE DENSITY AND A METHOD FOR IMPLANTING A DEVICE FOR MONITORING BONE DENSITY | November 2022 | March 2026 | Allow | 40 | 2 | 1 | Yes | No |
| 17981609 | SURGICAL INSTRUMENT FOR ENERGY-BASED TISSUE TREATMENT | November 2022 | December 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17981765 | VISUAL PROSTHESIS EMPLOYING VENTRICULAR OR ENDOVASCULAR NEURAL ELECTRODE ARRAYS | November 2022 | February 2025 | Allow | 28 | 3 | 0 | Yes | No |
| 17969185 | FLUID PUMP HAVING A RADIALLY COMPRESSIBLE ROTOR | October 2022 | February 2024 | Allow | 16 | 1 | 0 | No | No |
| 17945875 | Swappable High Mating Cycle Fiber Connection Interface | September 2022 | July 2025 | Allow | 34 | 1 | 0 | No | No |
| 17911471 | PROCESSING UNIT AND METHOD FOR USE IN FETAL MONITORING | September 2022 | June 2025 | Allow | 33 | 1 | 0 | No | No |
| 17898711 | SYSTEMS AND METHODS FOR ENHANCING ANOMALY DETECTION USING A PATTERN DICTIONARY | August 2022 | November 2025 | Allow | 38 | 0 | 1 | No | No |
| 17897739 | NEUROMODULATION SYSTEM | August 2022 | June 2024 | Allow | 21 | 1 | 0 | No | No |
| 17802709 | CIRCUMFERENTIALLY WRAPPABLE ELECTRODE FOR USE WITH METAL SURGICAL IMPLANTS | August 2022 | March 2026 | Abandon | 43 | 1 | 1 | No | No |
| 17821435 | CONTACT DETECTION FOR PHYSIOLOGICAL SENSOR | August 2022 | March 2024 | Allow | 19 | 1 | 1 | Yes | No |
| 17818193 | METHOD AND DEVICE FOR FEEDBACK CONTROL OF NEURAL STIMULATION | August 2022 | April 2024 | Allow | 20 | 0 | 1 | No | No |
| 17759993 | Multi-Target Electrical Stimulation Circuit, Electrical Stimulator and Signal Output Method of Electrical Stimulator | August 2022 | June 2023 | Allow | 11 | 1 | 0 | No | No |
| 17876735 | DETECTING WALKING IN A WEARABLE CARDIOVERTER DEFBRILLATOR SYSTEM | July 2022 | December 2023 | Allow | 17 | 1 | 0 | No | No |
| 17866185 | METHOD AND SYSTEM FOR CARDIOVASCULAR DISEASE ASSESSMENT AND MANAGEMENT | July 2022 | October 2023 | Allow | 15 | 0 | 1 | No | No |
| 17863016 | AUTOMATED TISSUE TREATMENT DEVICES, SYSTEMS, AND METHODS | July 2022 | May 2025 | Allow | 35 | 1 | 0 | No | No |
| 17854768 | METHODS AND SYSTEMS FOR HEART FAILURE PREVENTION AND TREATMENTS USING ULTRASOUND AND LEADLESS IMPLANTABLE DEVICES | June 2022 | July 2024 | Allow | 25 | 3 | 0 | Yes | No |
| 17840341 | METHOD AND APPARATUS FOR CHARGE BALANCING DURING DELIVERY OF ELECTRICAL STIMULATION | June 2022 | May 2025 | Allow | 36 | 5 | 0 | Yes | No |
| 17805033 | MAGNETIC ELECTRODE COCHLEAR IMPLANT WITH IN-SITU STIMULATION ADJUSTMENTS | June 2022 | November 2025 | Allow | 41 | 1 | 0 | Yes | No |
| 17825786 | HEART FAILURE MANAGEMENT TO AVOID REHOSPITALIZATION | May 2022 | March 2023 | Allow | 10 | 0 | 0 | No | No |
| 17804282 | SYSTEM AND METHOD FOR LASER CORNEAL INCISIONS FOR KERATOPLASTY PROCEDURES | May 2022 | April 2024 | Allow | 23 | 1 | 1 | No | No |
| 17663971 | ROBOT-ASSISTED LASER SURGICAL SYSTEM | May 2022 | October 2023 | Allow | 17 | 0 | 1 | No | No |
| 17775835 | PUMP SYSTEM, CONTROL UNIT AND METHOD FOR OPERATING A PUMP SYSTEM | May 2022 | May 2025 | Allow | 36 | 1 | 1 | No | No |
| 17774164 | MASK APPARATUS | May 2022 | April 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17724652 | METHOD AND DEVICE FOR FEEDBACK CONTROL OF NEURAL STIMULATION | April 2022 | May 2022 | Allow | 1 | 0 | 0 | No | No |
| 17769612 | Compact Laser-Steering End Effector | April 2022 | November 2024 | Allow | 31 | 0 | 1 | No | No |
| 17768162 | PHYSIOLOGICAL PARAMETER SENSING SYSTEMS AND METHODS | April 2022 | December 2024 | Allow | 32 | 2 | 0 | Yes | No |
| 17764103 | DIAGNOSIS SUPPORT SYSTEM AND DIAGNOSIS SUPPORT METHOD | March 2022 | January 2025 | Allow | 34 | 3 | 0 | Yes | No |
| 17698846 | PREVENTING CYTOKINE STORM IN COVID-19 PATIENTS BY SUPPRESSING CLONAL EXPANSION IN ACTIVATED LYMPHOCYTES USING ALTERNATING ELECTRIC FIELDS | March 2022 | April 2023 | Allow | 13 | 1 | 1 | No | No |
| 17692761 | PHOTOPLETHYSMOGRAPHY IN COMBINATION WITH MEDICAL DEVICES | March 2022 | February 2025 | Allow | 35 | 3 | 0 | Yes | No |
| 17640974 | METHOD OF OPERATING AN ELECTRICAL STIMULATION DEVICE WITH TWO OR MORE STIMULATION ENERGY SUPPLIES, AND A STIMULATING DEVICE | March 2022 | September 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17653672 | System for Neurostimulation Signal Reconstruction | March 2022 | March 2025 | Allow | 37 | 0 | 0 | No | No |
| 17686489 | HANDHELD WOUND CARE DEVICE | March 2022 | July 2025 | Abandon | 40 | 2 | 1 | No | No |
| 17639196 | Polyphonic Pitch Enhancement in a Cochlear Implant | February 2022 | January 2025 | Allow | 35 | 1 | 0 | No | No |
| 17651500 | DIRECTIONAL STIMULATION PROGRAMMING | February 2022 | January 2024 | Allow | 22 | 1 | 0 | No | No |
| 17651374 | DYNAMICALLY OPTIMIZED NEURAL SENSING | February 2022 | April 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17667009 | CLOSED-LOOP AUTOCALIBRATION METHOD FOR A COMPUTER BRAIN INTERFACE DEVICE, COMPUTER PROGRAM AND COMPUTER BRAIN INTERFACE DEVICE | February 2022 | May 2025 | Allow | 39 | 1 | 1 | No | No |
| 17588080 | METHOD AND SYSTEM FOR ACQUIRING DATA FOR ASSESSMENT OF CARDIOVASCULAR DISEASE | January 2022 | August 2023 | Allow | 19 | 0 | 1 | No | No |
| 17585961 | VISUAL PROSTHESIS EMPLOYING VENTRICULAR OR ENDOVASCULAR NEURAL ELECTRODE ARRAYS | January 2022 | June 2022 | Allow | 4 | 0 | 1 | No | No |
| 17582695 | CONTINGENT CARDIO-PROTECTION FOR EPILEPSY PATIENTS | January 2022 | May 2025 | Allow | 39 | 1 | 1 | No | No |
| 17629446 | DEEP END-TO-END CLASSIFICATION OF ELECTROCARDIOGRAM DATA | January 2022 | April 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17576380 | CARDIAC PACING LEAD | January 2022 | January 2023 | Allow | 12 | 1 | 1 | No | No |
| 17568679 | Systems and Methods for Detecting and Characterizing Pain | January 2022 | February 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17621665 | ELECTROCARDIOGRAM DATA CLASSIFICATION METHOD, COMPUTER DEVICE, AND STORAGE MEDIUM | December 2021 | September 2025 | Allow | 44 | 3 | 0 | No | No |
| 17554973 | TINNITUS TREATMENT AND ANALYSIS | December 2021 | April 2025 | Allow | 39 | 1 | 1 | Yes | No |
| 17620403 | PHOTOTHERAPY DEVICE AND PHOTOTHERAPY INSTRUMENT USED FOR IRRADIATION OF THE HEAD, AND THERAPY METHOD THEREOF | December 2021 | May 2025 | Allow | 41 | 3 | 0 | No | No |
| 17552866 | DORSAL SPINAL COLUMN CHARACTERIZATION WITH EVOKED POTENTIALS | December 2021 | July 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17619215 | Treatment of Acute Medical Conditions | December 2021 | October 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17548506 | CONTINGENT CARDIO-PROTECTION FOR EPILEPSY PATIENTS | December 2021 | September 2024 | Allow | 33 | 1 | 1 | No | No |
| 17545248 | Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields) | December 2021 | September 2023 | Allow | 21 | 1 | 0 | No | No |
| 17541939 | ROBUST ADAPTIVE BRAIN STIMULATION | December 2021 | June 2023 | Allow | 19 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HULBERT, AMANDA K.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 23.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HULBERT, AMANDA K works in Art Unit 3792 and has examined 268 patent applications in our dataset. With an allowance rate of 89.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.
Examiner HULBERT, AMANDA K's allowance rate of 89.9% places them in the 73% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by HULBERT, AMANDA K receive 1.69 office actions before reaching final disposition. This places the examiner in the 35% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by HULBERT, AMANDA K is 34 months. This places the examiner in the 45% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a -0.3% benefit to allowance rate for applications examined by HULBERT, AMANDA K. This interview benefit is in the 12% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 34.2% of applications are subsequently allowed. This success rate is in the 75% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 33.7% of cases where such amendments are filed. This entry rate is in the 50% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 56.1% are granted (fully or in part). This grant rate is in the 58% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 1.5% of allowed cases (in the 71% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.7% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.